Skip to main content
Caplight Logo









Particella

Particella

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://particella.bio/

Last Round

Grant

Nov 13, 2024

Total Funding Raised

$9.14M

Company Overview

Particella is a biotechnology company that develops oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPoral drug deliverymRNA therapeuticsnucleic acid deliveryoral biologicsintestinal epitheliumdrug delivery platformbiotech drug discoverynon-invasive deliverypill-based mRNAoral mRNApreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Particella Comparables

Compare Particella with similar companies based on industry and business-model similarity.

Particella comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hopewell Therapeutics
82%
Oragen Therapeutics
82%
ReCode Therapeutics
67%

Particella Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 13, 2024
Series AApr 1, 2022
GrantOct 5, 2020
SeedAug 8, 2018
AcceleratorMay 31, 2017

Particella Investors

Notable investors and investment history

Particella investors
InvestorRounds
Blue Bear VenturesSeed
Gates FoundationGrant
Berkeley Catalyst FundSeed
IndieBioAccelerator
Baldota Family OfficeSeed
SVE CapitalSeed
SOSVSeries A, Seed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 4, 2025

    Monthly visitors increased 2538% MoM, from 32 to 844.

  • Nov 10, 2024

    Monthly visitors increased 111% MoM.

Particella Filings

Explore SEC and related filing metadata, where available.

Particella filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Particella's valuation, stock price, and market status.

Is Particella a public or private company?

Particella is a private company.

What is the current stock price of Particella?

Particella is a private company with no public stock price. No recent secondary market data is available.

How much is Particella worth (valuation)?

Valuation information for Particella is not publicly available.

Can I buy Particella stock?

Particella shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Particella's last funding round?

Funding round information for Particella is not publicly available.

Who are the main investors in Particella?

Investor information for Particella is not publicly disclosed.

Will Particella IPO soon?

No public IPO plans have been announced for Particella.

How can I track Particella secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Particella's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2016
Last FundingNov 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?